Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257-Reference-Cited by-同舟云学术

Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257

Published:1997-11 Issue:1 Volume:339 Page:43-51
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Thollon Catherine,Bidouard Jean-Pierre,Cambarrat Christine,Lesage Ludovic,Reure Hélène,Delescluse Isabelle,Vian Joël,Peglion Jean-Louis,Vilaine Jean-Paul

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with β-adrenergic blocking properties;Argentieri;J. Cardiovasc. Pharmacol.,1993

2. An analysis of the time-relations of electrocardiograms;Bazett;Heart,1920

3. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells;Bois;Br. J. Pharmacol.,1996

4. Inhibitory actions of Zeneca ZD7288 on whole-cell hyperpolarization activated inward current (If) in guinea-pig dissociated sinoatrial node cells;BoSmith;Br. J. Pharmacol.,1993

5. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: Etiology and interventions;Carlsson;J. Cardiovasc. Pharmacol.,1990

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese natural compound decreases pacemaking of rabbit cardiac sinoatrial cells by targeting second messenger regulation of f-channels;eLife;2022-03-22

2. The natural compound TMYX reduces SAN cells rate by antagonizing the cAMP modulation of f-channels;2021-11-20

3. Heart Rate Reduction Improves Right Ventricular Function and Fibrosis in Pulmonary Hypertension;American Journal of Respiratory Cell and Molecular Biology;2020-12

4. Beneficial Effects of Ivabradine on Post-Resuscitation Myocardial Dysfunction in a Porcine Model of Cardiac Arrest;Shock;2020-05

5. Ivabradine and endothelium: an update;Therapeutic Advances in Cardiovascular Disease;2020-01